GO
Loading...

Biotech and Pharmaceuticals

More

  • 2015's strong outlook for healthcare IPOs  Thursday, 29 Jan 2015 | 5:40 AM ET

    Cathrin Petty, co-head of EMEA healthcare at JP Morgan, says the U.K. has the capacity to be a successful market for life sciences, and the year ahead for healthcare IPOs looks strong.

  • The rise and rise of life sciences  Thursday, 29 Jan 2015 | 4:55 AM ET

    George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.

  • Cracking down on cat allergies  Thursday, 29 Jan 2015 | 4:30 AM ET

    Steve Harris, CEO of Circassia, says his company is combating allergies by tackling how they affect people's immune systems, rather than simply making products that provide "symptomatic relief".

  • Drugmakers get mysterious invites to White House Wednesday, 28 Jan 2015 | 5:06 PM ET
    President Barack Obama

    The heads of research at several large drugmakers have received mysterious invitations to the White House for a meeting Friday morning.

  • Amgen profit tops expectations Tuesday, 27 Jan 2015 | 5:04 PM ET
    Amgen building in South San Francisco, California.

    Amgen on Tuesday reported higher-than-expected fourth-quarter profit.

  • Bristol-Myers quarterly profit beats forecasts Tuesday, 27 Jan 2015 | 9:22 AM ET
    Bristol-Myers Squibb R&D headquarters.

    Bristol-Myers Squibb reported higher-than-expected earnings, helped by strong sales of its hepatitis C drugs and its Eliquis blood clot preventer.

  • Pfizer's 2015 forecast disappoints, hit by dollar Tuesday, 27 Jan 2015 | 7:36 AM ET

    Pfizer reported stronger-than-expected quarterly results as sales of vaccines and cancer drugs increased.

  • Impact of a strong U.S. dollar  Tuesday, 27 Jan 2015 | 5:50 AM ET

    Cole Smead, portfolio manager at Smead Capital Management, discusses the strong U.S. dollar and how it will affect sectors like pharmaceuticals.

  • Novartis flags faster sales, profit growth for 2015 Tuesday, 27 Jan 2015 | 2:48 AM ET
    Joe Jimenez, CEO of Novartis, at 2015 WEF in Davos, Switzerland.

    Novartis forecast sales and profits to grow at a faster pace this year driven by recent drug successes and its portfolio overhaul.

  • First case of H7N9 bird flu found in North America Monday, 26 Jan 2015 | 5:18 PM ET
    A technician deals with test reagents for bird flu virus

    Canadian health authorities say they have diagnosed the first case of bird flu in a British Columbia woman who recently returned from China.

  • Bird flu detected at California turkey farm Monday, 26 Jan 2015 | 12:45 PM ET

    A California turkey farm has been quarantined after confirmation of an outbreak of the highly pathogenic H5N8 avian influenza strain.

  • Scientists unboil an egg, and it may be a big deal Friday, 23 Jan 2015 | 4:13 PM ET

    The ability to unfold a protein and return it to its original state could save money in everything from cancer research to food production.

  • Ebola vaccine trials to begin in Liberia Thursday, 22 Jan 2015 | 3:45 PM ET
    Health workers wearing protective equipment are pictured at the Island Clinic in Monrovia, Liberia.

    A clinical trial of two experimental Ebola vaccines is expected to start in Liberia in the next couple of weeks, the NIH said.

  • Drug-laden drone crashes near US-Mexico border Thursday, 22 Jan 2015 | 10:57 AM ET
    In this image released by the Tijuana Municipal Police on Jan. 21, 2015, a drone loaded with methamphetamine lies on the ground after it crashed into a supermarket parking lot in the city of Tijuana on Tuesday Jan. 20, 2015.

    Police in a Mexican border city said that a drone overloaded with illicit methamphetamine crashed into a supermarket parking lot.

  • Meet San Francisco's new weed of the month club Wednesday, 21 Jan 2015 | 4:02 PM ET

    Marvina is a premium cannabis provider that offers a monthly delivery service of marijuana to consumers in San Francisco.

  • Bristol-Meyers Squibb taps a doctor as new CEO Tuesday, 20 Jan 2015 | 5:29 PM ET
    Bristol-Myers Squibb R&D headquarters.

    Pharmaceutical giant Bristol-Myers Squibb named Dr. Giovanni Caforio as its new CEO on Tuesday.

  • Vaccinating children becoming unaffordable: Report Tuesday, 20 Jan 2015 | 2:22 PM ET
    A child receives a vaccine in a makeshift field clinic of the Doctors Without Borders (MSF) organisation during a vaccination program against measles in Bangui, Central African Republic.

    The cost of a vaccination program is 68 times more expensive than is was in 2001. Doctors Without Borders wants companies to slash prices.

  • Davos: Who needs a 'wake up call'?  Tuesday, 20 Jan 2015 | 11:25 AM ET

    Discussing the current state of Europe at Davos 2015, Karl-Ludwig Kley, chairman of Merck says the lack of coordination and cohesion in European businesses is the current problem.Meanwhile political leaders need a wake-up call.

  • Supreme Court rules for Teva over drug patent Tuesday, 20 Jan 2015 | 10:48 AM ET
    An employee collects newly-manufactured pills at Teva Pharmaceutical Industries headquarters in Jerusalem, Israel.

    The U.S. Supreme Court ruled for Teva Pharmaceutical Industries in its fight with generic drug manufacturers over patent protections.

  • Benefits firms shouldn't play drug favorites: CEO Tuesday, 20 Jan 2015 | 10:00 AM ET

    Regeneron Pharmaceuticals CEO Dr. Leonard Schleifer told CNBC on Tuesday that benefits companies should not try to practice medicine.

Contact Biotech and Pharma

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More

 

  • Dan Mangan is a reporter covering health care for CNBC.com.

  • Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.

  • Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.